NCT03558841

Brief Summary

This study evaluates the effect of the addition of gait training to physical therapy on the gait of geriatric rehabilitation inpatients. Half of the patients will receive gait training with a gait training machine and conventional physical therapy in combination, the other half of the patients will receive conventional physical therapy alone.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 5, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 15, 2018

Completed
Last Updated

June 15, 2018

Status Verified

June 1, 2018

Enrollment Period

6 months

First QC Date

May 16, 2018

Last Update Submit

June 5, 2018

Conditions

Keywords

gaitmobilitygeriatricrehabilitationinpatient

Outcome Measures

Primary Outcomes (1)

  • Change in gait velocity

    Habitual, preferred ("normal") walking speed (cm/s) quantified with the GAITRite electronic walkway system

    Baseline, after 2 weeks, after 4 weeks

Secondary Outcomes (9)

  • Change in grip strength

    Baseline, after 2 weeks, after 4 weeks

  • Change in general mobility

    Baseline, after 2 weeks, after 4 weeks

  • Change in spatial-temporal gait parameters (other than walking velocity)

    Baseline, after 2 weeks, after 4 weeks

  • Change in endurance

    Baseline, after 2 weeks, after 4 weeks

  • Change in functionality (DEMMI total score, absolute values)

    Baseline, after 2 weeks, after 4 weeks

  • +4 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Gait training with the THERA-Trainer Lyra (3x/week) in addition to conventional geriatric rehabilitation physical therapy (6x/week) during inpatient period. After discharge home, continuation of Lyra gait training (3x/week), discontinuation of physical therapy.

Other: Gait training with the THERA-Trainer LyraOther: Physical therapy

Control Group

ACTIVE COMPARATOR

Conventional geriatric rehabilitation physical therapy (6x/week) during inpatient period. After discharge home, discontinuation of physical therapy.

Other: Physical therapy

Interventions

Gait training with the THERA-Trainer Lyra end-effector gait trainer 3x/week during the inpatient and the outpatient periods.

Intervention Group

Conventional geriatric rehabilitation physical therapy (6x/week) during the inpatient period. After discharge home, discontinuation of physical therapy.

Control GroupIntervention Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years of age or older
  • Rehabilitation inpatients at Felix Platter Hospital with primarily muscle weakness and difficulty walking
  • Community-dwellers before hospital admission with planned discharge home
  • Body weight 150 kg or less
  • Body height between 100 cm and 195 cm
  • Mini-Mental State Examination score 21 points or more
  • Signed informed consent for study participation

You may not qualify if:

  • Clinically significant neurologic or musculoskeletal diseases which severly affect walking, e.g. advanced Parkinson's disease or hemiplegia
  • Severe cardiac insufficiency
  • Advanced chronic pulmonary disease (COPD Gold IV)
  • Amputations of extremities (except missing fingers)
  • Blindness
  • Inability to understand and speak German well enough to understand the patient information, training and assessment instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Felix Platter Hospital

Basel, 4002, Switzerland

Location

MeSH Terms

Conditions

Mobility LimitationMuscle Weakness

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic Processes

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Stephanie A. Bridenbaugh, M.D

    Head of the Basel Mobility Center of the Felix Platter Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized, active-controlled
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2018

First Posted

June 15, 2018

Study Start

October 5, 2017

Primary Completion

March 29, 2018

Study Completion

March 29, 2018

Last Updated

June 15, 2018

Record last verified: 2018-06

Locations